Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PANAMA: Dipyrone + Caffeine + Chlorpheniramine in Common Cold and Flu
NCT07626437Phase 3Recruiting
- Sponsor
- Brainfarma
- Start
- May 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 3 trial of Metamizole sodium, caffeine, chlorpheniramine in common cold, influenza, sponsored by Brainfarma. Started May 2026; status: recruiting.
02
Drugs
Metamizole sodiumcaffeinechlorpheniramine
03
Conditions
common coldinfluenza
Beyond the preview
Go deeper on NCT07626437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07626437.